Atlas Trials

Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145

Clinical trial NCT01947777 · COMPLETED

Trial details

NCT number
NCT01947777
Sponsor
SecuraBio
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2013-10-01
Primary completion
2013-11-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.